EMJ Crypto Technologies Inc. and CCC Crypto Corp.
private/SRx Health Solutions, Inc.privateSRx Health Solutions acquires EMJ Crypto Technologies and CCC Crypto Corp
Deal value
—
stock
Per-share offer
—
Premium
—
Days to close
—
Term fee
—
No structured deal economics extracted yet. Re-run the scanner or fall back to the source filing below.
Announced
Apr 24, 2026
Preliminary Proxy
—
Definitive Proxy
—
Record date
—
Shareholder vote
Dec 12, 2025
Expected close
—
No regulatory or closing-conditions data extracted yet. The merger agreement Exhibit 10.1 contains this in the “Conditions to Closing” and “Regulatory Approvals” articles.
- ✓Shareholder approval· 51.15% of outstanding voting capital stock (written consent)
No competing-bidder, activist, or dissident-proxy signals in the database for this target.
Acquirer side· SRx Health Solutions, Inc.
Legal
Meister Seelig & Schuster PLLC
- · Louis Lombardo
- · William P. Hubbard
“Louis Lombardo, Esq. William P. Hubbard Esq. Meister Seelig & Schuster PLLC 125 Park Avenue, 7th Floor New York, New York 10017 Tel: (212) 655-3500”
Target side· EMJ Crypto Technologies Inc. and CCC Crypto Corp.
Legal
- · Richard Raymer
“Richard Raymer Dorsey & Whitney LLP TD Bank Tower 66 Wellington Street West, Suite 3400 Toronto, ON M5K 1E6 Tel: +1 (416) 367-7370”
| Firm | Role | Side | Deals in DB | |
|---|---|---|---|---|
| Meister Seelig & Schuster PLLC | Legal | Acquirer | 1 | View deals → |
| Dorsey & Whitney LLP | Legal | Target | 1 | View deals → |
SRx Health Solutions, Inc. is acquiring EMJ Crypto Technologies Inc., CCC Crypto Corp., and 100% of intellectual property rights to an AI-based trading algorithm via a Share Exchange and Asset Transfer Agreement dated December 16, 2025 (amended March 11, 2026). The transaction involves issuance of up to 418,250,951 shares of common stock as consideration, consisting of 179,814,780 shares, 125,475,285 exchangeable shares, and 112,960,886 pre-funded warrant shares. Stockholders holding 51.15% of outstanding voting capital stock approved the transaction by written consent on December 12, 2025, satisfying the 20% or greater share issuance requirement under NYSE American rules.